Novo Nordisk’s Wegovy® (semaglutide 2.4 mg) was associated with liver health–related benefits not solely driven by weight ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...

New obesity treatments, including ‘oral Mounjaro’ and ‘high-dose Wegovy,’ are scheduled to be launched next year. The Danish ...

Full meals are being swapped for grazing, according to a new study - with the rise of weight loss jabs said to be encouraging ...

Amy Schumer has hit back at the scrutiny surrounding her absent wedding ring amid rumors of marital woes with husband Chris Fischer.

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

" We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger than India. We are in ...

The first of its kind medical trial will see cats take a specially-designed weight loss drug designed to help them lose ...

This follows recent successful efforts by the Trump administration to cut the price of this compound for certain patients.

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Recent estimates suggest that about 60% of the nation’s cats and dogs have obesity; hundreds of thousands of cats and dogs have diabetes. Better treatments are desperately needed, experts said.